SARS-CoV-2 and COVID-19 immunopathogenesis have several pathways. Therapies that prevent viral infection and regulate defective immune responses may stop numerous diseases. When developing and testing COVID-19 vaccines, consider immune dysfunction and disease severity. More research is needed on the host immune response to SARS-CoV-2, especially healthy versus dysfunctional consequences. These help detect immunological correlates of protection and illness severity for patient triage.
Dr. KK Aggarwal
President Heart Care Foundation of India and Group Editor in Chief MEDtalks
Dr. Avijit Royzada
Physician, Sai Baba Hospital Heart And Kidney Centre, Bilaspur, Chhattisgarh